Tengable

Developer of an implantable medical device designed to restore the sense of touch for people who have lost tactile sensation due to injury, disease, or surgery.

Therapeutic Devices
Active
Pre-Funding Yokne'am Illit, Israel Founded 2023
Last updated 2026-09-06
Total raised
—
Stage
Pre-Funding
Founded
2023
Headcount
8
HQ
Yokne'am Illit, Israel
Sector
Therapeutic Devices

About

Tengable is an Israeli startup developing a subcutaneous platform to restore the sense of touch to those who have lost it due to nerve damage, injury, or illness. The company's solution involves a small, extremely thin sensor implanted under the skin that creates an an electric charge upon contact with an object. This charge is then sent through an electrode to a healthy nerve ending, re-installing the sensation of touch. Tengable's device, called Re-Sense, is the first implantable device that restores both touch and temperature sensations. The company's technology is based on triboelectric nanogenerators (TENGs), which convert mechanical movement into electrical energy, eliminating the need for an external power source. Tengable aims to provide a solution for patients when other treatments are no longer viable, as its sensor is not tied to a healing process.

Funding history · 1 round · — total

1 event/round · — Total Funding
Oct 2024
Grant Undisclosed teng-able.com ↗
★ Ministry of Health★ Galil Ofek Innovation★ Israel Innovation Authority★ Ramot at Tel Aviv University★ Medical Innovations Incubator

Headcount over time

8 employees (2026-09) · 1 point
8 8 2026-09

Offices

Yokne'am Illit, Israel · HQ / main office

Q&A

What is Tengable's primary focus?
Tengable is developing an implantable medical device designed to restore the sense of touch for individuals who have lost tactile sensation due to injury, disease, or surgery.
What is the name of Tengable's core product?
Tengable's device is called Re-Sense, and it is designed to restore both touch and temperature sensations.
What technology does Tengable's device utilize?
Tengable's technology is based on triboelectric nanogenerators (TENGs), which convert mechanical movement into electrical energy, eliminating the need for an external power source.
What was Tengable's most recent funding event?
In January 2025, Tengable received a Grant of $1,000,000.
Which investors participated in Tengable's Seed round in October 2024?
The Seed round in October 2024 included investments from Medical Innovations Incubator and Ramot at.
Who are the co-founders of Tengable?
The co-founders of Tengable are Prof. Ben Maoz, who also serves as CTO, and Dr. Amir Arami, who is the CMO.

Team · 10

Prof. Ben M. Maoz, PhD
Founder · CTO and Co Founder
Amir Arami, MD
Founder · CMO and Co Founder
Shai Feinsod
CEO
Maximiliano (Max) Sisti
Director of R&D
Yechiam Sapir
Director of Clinical Affairs
Arkady Glukhovsky
Development Engineer
Netta Deutschman
CFO
Noa Meiri
Design & Digital Media
Eden Nashnaz
Developer
Keren Trink
Occupational Therapist

Sectors & technology

Primary sector
Therapeutic Devices
Technologies
Target customers
Business model
B2B

Tags

sensorsmedical-devicesnanotechnologychronic-disease
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteteng-able.com/
LinkedInlinkedin.com/company/96048033

Identifiers & details

Founded2023
Employees (exact)8

Radar intelligence

Web history (Wayback)

Domainteng-able.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516725843
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-12-22
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens1
Registry events4 — charge (1), shares_capital (2), other (1)
Registered addressהתנופה 3 יקנעם עילית

Recent registry events

DateEvent
2026-04-14רישום שעבוד
2026-08-03הקצאת מניות
2026-08-02שינוי בתקנון
2026-08-02שינוי בהרכב הון - מניות-פיצול מניה